Correlation Between Dermata Therapeutics and ZyVersa Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dermata Therapeutics and ZyVersa Therapeutics, you can compare the effects of market volatilities on Dermata Therapeutics and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and ZyVersa Therapeutics.
Diversification Opportunities for Dermata Therapeutics and ZyVersa Therapeutics
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Dermata and ZyVersa is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and ZyVersa Therapeutics go up and down completely randomly.
Pair Corralation between Dermata Therapeutics and ZyVersa Therapeutics
Given the investment horizon of 90 days Dermata Therapeutics is expected to generate 1.43 times more return on investment than ZyVersa Therapeutics. However, Dermata Therapeutics is 1.43 times more volatile than ZyVersa Therapeutics. It trades about -0.04 of its potential returns per unit of risk. ZyVersa Therapeutics is currently generating about -0.11 per unit of risk. If you would invest 689.00 in Dermata Therapeutics on August 27, 2024 and sell it today you would lose (575.00) from holding Dermata Therapeutics or give up 83.45% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dermata Therapeutics vs. ZyVersa Therapeutics
Performance |
| Timeline |
| Dermata Therapeutics |
| ZyVersa Therapeutics |
Dermata Therapeutics and ZyVersa Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dermata Therapeutics and ZyVersa Therapeutics
The main advantage of trading using opposite Dermata Therapeutics and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.| Dermata Therapeutics vs. Zura Bio Limited | Dermata Therapeutics vs. Phio Pharmaceuticals Corp | Dermata Therapeutics vs. Sonnet Biotherapeutics Holdings | Dermata Therapeutics vs. 180 Life Sciences |
| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |